Pharmaco-economical analysis of Russian QUADRIGA Study data
Aim. To assess antihypretensive effect quality and duration for ACE inhibitor spirapril (Quadropril®; daily dose 6 mg) among arterial hypertension (AH) patients, in real-world out-patient clinical settings. Material and methods. The trial involved 11 Russian cities. This Russian multi-center, non-co...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2006-04-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1163 |